We are pleased to invite investors and analysts to participate in our virtual event on Tuesday, 23 March 2021 highlighting future growth drivers of the Division. We will welcome you to the event in our new virtual 360° platform which will be accessible one day prior to the event (as of 15:00 CET). We would like to invite you to visit our virtual marketplace and participate in a self-guided virtual showroom tour. Stay tuned! 14:00-16:00 CET / 13:00-15:00 GMT 9:00-11:00am EDT / 6:00-8:00am PDT The event will address the following topics:   Diagnostics market opportunities, strategy and organisation Overview on R&D and new technologies Late stage pipeline: Systems and diagnostics solutions for selected disease areas such as infectious diseases, cardiology and oncology Speakers will include:   Thomas Schinecker, CEO Roche Diagnostics Ann Costello, Global Head Roche Diagnostics Solutions Palani Kumaresan, Global Head of Research & Development Benjamin Lilienfeld, Life Cycle Leader Serum Work Area Systems Michael Hombach, Global Clinical Leader Infectious Diseases Andre Ziegler, Global Clinical Leader Cardiology Jill German, Global Head of Pathology Lab The webinar will start with presentations, followed by a Q&A session (live access to the speakers). If you want to benefit from the entire platform (e.g. visit of virtual showroom) please register here  by today, 15 March 2021. A replay of the event will be available via > ir.roche.com *privacy notice Best regards, Karl Mahler                                                     Birgit Masjost Head of Investor Relations and                      Investor Relations Officer Roche Group Planning

Roche Investor Relations
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com	Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com	Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com

get the latest news and updates to your inbox.